BBP vs. FBIOX

Last updated Jun 4, 2026

BBP (Virtus LifeSci Biotech Products ETF) and FBIOX (Fidelity Select Biotechnology Portfolio) are both Health & Biotech Equities funds. Over the past 10 years, BBP returned 11.61%/yr vs 9.09%/yr for FBIOX. Their correlation of 0.91 suggests significant overlap in exposure. BBP charges 0.79%/yr vs 0.69%/yr for FBIOX.

Performance

BBP vs. FBIOX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Virtus LifeSci Biotech Products ETF (BBP) and Fidelity Select Biotechnology Portfolio (FBIOX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BBP achieves a 5.80% return, which is significantly higher than FBIOX's 0.03% return. Over the past 10 years, BBP has outperformed FBIOX with an annualized return of 11.61%, while FBIOX has yielded a comparatively lower 9.09% annualized return.

BBP

• 1D: 1.18%
• 1M: -3.14%
• YTD: 5.80%
• 6M: 7.91%
• 1Y: 45.02%
• 3Y*: 16.70%
• 5Y*: 10.37%
• 10Y*: 11.61%

FBIOX

• 1D: -3.67%
• 1M: -3.79%
• YTD: 0.03%
• 6M: -0.21%
• 1Y: 42.15%
• 3Y*: 15.71%
• 5Y*: 5.77%
• 10Y*: 9.09%

*Multi-year figures are annualized to reflect compound growth (CAGR)

BBP vs. FBIOX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
BBP Virtus LifeSci Biotech Products ETF	5.80%	33.15%	3.32%	17.88%	0.85%	-8.17%	22.24%	24.73%	-13.95%	24.07%
FBIOX Fidelity Select Biotechnology Portfolio	0.03%	36.38%	7.26%	10.09%	-15.87%	-12.26%	38.62%	36.12%	-10.92%	27.87%

Correlation

The correlation between BBP and FBIOX is 0.85, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.85
Correlation (3Y) Calculated over the trailing 3-year period	0.88
Correlation (5Y) Calculated over the trailing 5-year period	0.91
Correlation (10Y) Calculated over the trailing 10-year period	0.91
Correlation (All Time) Calculated using the full available price history since Dec 18, 2014	0.91

The correlation between BBP and FBIOX has been stable across timeframes, ranging from 0.85 to 0.91 - a consistent structural relationship.

BBP vs. FBIOX - Sectors Allocation Comparison

Sectors	BBP	FBIOX
Healthcare	100.0%	100.0%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Financial Services	-	-
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

BBP vs. FBIOX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BBP

BBP Risk / Return Rank: 65
BBP Sharpe Ratio Rank: 56
BBP Sortino Ratio Rank: 56
BBP Omega Ratio Rank: 50
BBP Calmar Ratio Rank: 86
BBP Martin Ratio Rank: 79

FBIOX

FBIOX Risk / Return Rank: 66
FBIOX Sharpe Ratio Rank: 53
FBIOX Sortino Ratio Rank: 50
FBIOX Omega Ratio Rank: 43
FBIOX Calmar Ratio Rank: 95
FBIOX Martin Ratio Rank: 90

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BBP vs. FBIOX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Products ETF (BBP) and Fidelity Select Biotechnology Portfolio (FBIOX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BBP	FBIOX	Difference
Sharpe ratio: Return per unit of total volatility	1.91	2.15	-0.24
Sortino ratio: Return per unit of downside risk	2.73	2.96	-0.22
Omega ratio: Gain probability vs. loss probability	1.32	1.35	-0.04
Calmar ratio: Return relative to maximum drawdown	4.87	5.81	-0.93
Martin ratio: Return relative to average drawdown	15.32	18.24	-2.92
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BBP vs. FBIOX - Sharpe Ratio Comparison

The current BBP Sharpe Ratio is 1.91, which is comparable to the FBIOX Sharpe Ratio of 2.15. The chart below compares the historical Sharpe Ratios of BBP and FBIOX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	BBP	FBIOX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.91	2.15	-0.24
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.40	0.23	+0.16
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.42	0.35	+0.08
Sharpe Ratio (All Time) Calculated using the full available price history	0.39	0.47	-0.08

Drawdowns

BBP vs. FBIOX - Drawdown Comparison

The maximum BBP drawdown since its inception was -44.32%, smaller than the maximum FBIOX drawdown of -71.98%. Use the drawdown chart below to compare losses from any high point for BBP and FBIOX.

Drawdown Indicators

	BBP	FBIOX	Difference
Max Drawdown Largest peak-to-trough decline	-44.32%	-71.98%	+27.66%
Max Drawdown (1Y) Largest decline over 1 year	-9.28%	-7.62%	-1.66%
Max Drawdown (3Y) Largest decline over 3 years	-26.09%	-27.83%	+1.74%
Max Drawdown (5Y) Largest decline over 5 years	-38.28%	-44.87%	+6.59%
Max Drawdown (10Y) Largest decline over 10 years	-44.32%	-48.66%	+4.34%
Current Drawdown Current decline from peak	-6.47%	-7.02%	+0.55%
Average Drawdown Average peak-to-trough decline	-12.02%	-23.63%	+11.61%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.95%	2.42%	+0.53%

Volatility

BBP vs. FBIOX - Volatility Comparison

Virtus LifeSci Biotech Products ETF (BBP) and Fidelity Select Biotechnology Portfolio (FBIOX) have volatilities of 7.61% and 7.50%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BBP	FBIOX	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.61%	7.50%	+0.11%
Volatility (6M) Calculated over the trailing 6-month period	18.43%	16.31%	+2.12%
Volatility (1Y) Calculated over the trailing 1-year period	23.76%	20.71%	+3.05%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	26.35%	24.96%	+1.39%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	27.40%	26.25%	+1.15%

BBP vs. FBIOX - Expense Ratio Comparison

BBP has a 0.79% expense ratio, which is higher than FBIOX's 0.69% expense ratio.

Dividends

BBP vs. FBIOX - Dividend Comparison

BBP has not paid dividends to shareholders, while FBIOX's dividend yield for the trailing twelve months is around 6.72%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BBP Virtus LifeSci Biotech Products ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.18%	0.00%	1.29%
FBIOX Fidelity Select Biotechnology Portfolio	6.72%	2.47%	1.21%	0.45%	0.00%	14.48%	19.46%	8.89%	11.18%	1.41%	3.42%	6.71%

Frequently Asked Questions

Can I hold both BBP and FBIOX in my portfolio?

BBP and FBIOX have a correlation of 0.85, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BBP or FBIOX?

BBP has higher volatility (7.61%) compared to FBIOX (7.50%). In terms of maximum drawdown, BBP dropped -44.32% vs FBIOX's -71.98%.

Which has better risk-adjusted returns?

FBIOX currently has the higher Sharpe Ratio (2.15 vs 1.91), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.